ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for APGE

Stock NameApogee Therapeutics, Inc. Common Stock
TickerAPGE(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate APGE holdings

News associated with APGE

Analysts Set Apogee Therapeutics Inc. (NASDAQ:APGE) PT at $97.29
Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) has received an average rating of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among analysts […] - 2025-09-02 03:06:53
XTX Topco Ltd Raises Stock Holdings in Apogee Therapeutics Inc. (NASDAQ:APGE)
XTX Topco Ltd raised its position in Apogee Therapeutics Inc. (NASDAQ:APGE – Free Report) by 170.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,188 shares of the company’s stock after buying an additional 10,840 shares during the quarter. […] - 2025-08-06 05:16:59
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives $99.00 Average Price Target from Brokerages
Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have covered the stock in the last year […] - 2025-07-14 02:22:47
Apogee Therapeutics Sees Unusually High Options Volume (NASDAQ:APGE)
Apogee Therapeutics Inc. (NASDAQ:APGE – Get Free Report) saw unusually large options trading activity on Monday. Traders acquired 3,810 put options on the company. This represents an increase of 728% compared to the average daily volume of 460 put options. Insiders Place Their Bets In related news, insider Carl Dambkowski sold 10,090 shares of the […] - 2025-07-09 02:50:45
Financial Review: Apogee Therapeutics (NASDAQ:APGE) vs. argenx (NASDAQ:ARGX)
argenx (NASDAQ:ARGX – Get Free Report) and Apogee Therapeutics (NASDAQ:APGE – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk. Profitability This table compares argenx and Apogee Therapeutics’ net […] - 2025-06-17 02:49:06
Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Rating of “Buy” from Brokerages
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has earned an average rating of “Buy” from the five brokerages that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have covered the stock in the last year is […] - 2025-06-16 04:11:05
Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC raised its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 90.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,344 shares of the company’s stock after acquiring an additional 17,301 shares during the […] - 2025-05-30 05:34:59
Millennium Management LLC Has $5.90 Million Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)
Millennium Management LLC boosted its position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 44.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 130,171 shares of the company’s stock after purchasing an additional 40,162 shares during the period. Millennium Management LLC’s holdings in Apogee Therapeutics were […] - 2025-05-28 04:56:52
Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives $94.60 Consensus PT from Analysts
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have received an average rating of “Buy” from the five ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have issued ratings on the stock in […] - 2025-05-27 05:56:59
ProShare Advisors LLC Increases Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)
ProShare Advisors LLC grew its position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 30.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,805 shares of the company’s stock after purchasing an additional 2,985 shares […] - 2025-05-26 05:18:49
We Did The Math SMLF Can Go To $77
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-06 08:38:07
Analyzing Apogee Therapeutics (NASDAQ:APGE) and Zura Bio (NASDAQ:ZURA)
Zura Bio (NASDAQ:ZURA – Get Free Report) and Apogee Therapeutics (NASDAQ:APGE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Profitability This table compares Zura Bio and […] - 2025-05-06 02:30:46
Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) Target Price at $92.17
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock in the […] - 2025-04-21 02:14:46
KLP Kapitalforvaltning AS Acquires Shares of 5,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)
KLP Kapitalforvaltning AS bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 5,000 shares of the company’s stock, valued at approximately $226,000. Other large investors have also recently made changes to their […] - 2025-04-08 04:32:50
Apogee Therapeutics, Inc. (NASDAQ:APGE) Position Reduced by Bank of New York Mellon Corp
Bank of New York Mellon Corp lowered its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 1.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 110,827 shares of the company’s stock after selling 1,774 shares during the period. Bank of New York Mellon Corp’s holdings in Apogee Therapeutics were worth $5,020,000 […] - 2025-03-18 05:09:01
Apogee Therapeutics (NASDAQ:APGE) Now Covered by Citigroup
Citigroup began coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note released on Thursday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $95.00 target price on the stock. A number of other brokerages have also recently issued reports on APGE. Canaccord Genuity Group assumed coverage on Apogee […] - 2025-03-14 05:48:55
Apogee Therapeutics (NASDAQ:APGE) Earns Outperform Rating from Wedbush
Wedbush reaffirmed their outperform rating on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note issued to investors on Tuesday morning,RTT News reports. The firm currently has a $90.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the stock. Canaccord Genuity Group assumed coverage […] - 2025-03-12 04:56:50
Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Handelsbanken Fonder AB
Handelsbanken Fonder AB trimmed its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) by 14.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,500 shares of the company’s stock after selling 1,300 shares during the period. Handelsbanken Fonder AB’s holdings […] - 2025-03-04 06:46:55
Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued ratings on […] - 2025-03-04 04:47:02
Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) PT at $89.71
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given an average rating of “Buy” by the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have covered the stock […] - 2025-02-05 04:06:46

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc APGE holdings

DateNumber of APGE Shares HeldBase Market Value of APGE SharesLocal Market Value of APGE SharesChange in APGE Shares HeldChange in APGE Base ValueCurrent Price per APGE Share HeldPrevious Price per APGE Share Held
2026-01-15 (Thursday)7,652APGE holding increased by 1144USD 617,899APGE holding increased by 81445USD 617,8991,144USD 81,445 USD 80.75 USD 82.4299
2026-01-14 (Wednesday)6,508APGE holding increased by 22USD 536,454APGE holding increased by 24060USD 536,45422USD 24,060 USD 82.4299 USD 79
2026-01-13 (Tuesday)6,486USD 512,394APGE holding increased by 8756USD 512,3940USD 8,756 USD 79 USD 77.65
2026-01-12 (Monday)6,486USD 503,638APGE holding decreased by -2205USD 503,6380USD -2,205 USD 77.65 USD 77.99
2026-01-09 (Friday)6,486USD 505,843APGE holding increased by 3308USD 505,8430USD 3,308 USD 77.99 USD 77.48
2026-01-08 (Thursday)6,486APGE holding increased by 22USD 502,535APGE holding decreased by -7798USD 502,53522USD -7,798 USD 77.48 USD 78.95
2026-01-07 (Wednesday)6,464USD 510,333APGE holding increased by 4525USD 510,3330USD 4,525 USD 78.95 USD 78.25
2026-01-06 (Tuesday)6,464USD 505,808APGE holding increased by 4783USD 505,8080USD 4,783 USD 78.25 USD 77.5101
2026-01-05 (Monday)6,464USD 501,025APGE holding increased by 11183USD 501,0250USD 11,183 USD 77.5101 USD 75.78
2026-01-02 (Friday)6,464USD 489,842APGE holding increased by 1939USD 489,8420USD 1,939 USD 75.78 USD 75.48
2025-12-31 (Wednesday)6,464USD 487,903APGE holding decreased by -1810USD 487,9030USD -1,810 USD 75.48 USD 75.7601
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of APGE by Blackrock for IE00B3VWM098

Show aggregate share trades of APGE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY1,14483.24080.553 80.822USD 92,460 47.89
2026-01-14BUY2284.56078.080 78.728USD 1,732 47.75
2026-01-08BUY2278.40075.130 75.457USD 1,660 47.23
2025-12-23SELL-2280.44077.020 77.362USD -1,702 45.91 Loss of -692 on sale
2025-12-03SELL-11074.99069.165 69.748USD -7,672 43.89 Loss of -2,844 on sale
2025-12-02BUY4470.07067.680 67.919USD 2,988 43.77
2025-11-25SELL-6671.13067.660 68.007USD -4,488 43.12 Loss of -1,643 on sale
2025-11-24SELL-6669.84067.370 67.617USD -4,463 43.00 Loss of -1,625 on sale
2025-11-17SELL-24267.10063.750 64.085USD -15,509 42.46 Loss of -5,234 on sale
2025-11-12SELL-2264.86961.405 61.751USD -1,359 42.13 Loss of -432 on sale
2025-11-06SELL-2256.00053.630 53.867USD -1,185 41.81 Loss of -265 on sale
2025-11-05SELL-22057.31052.760 53.215USD -11,707 41.74 Loss of -2,524 on sale
2025-11-04SELL-4454.71053.010 53.180USD -2,340 41.68 Loss of -506 on sale
2025-11-03SELL-4458.36053.530 54.013USD -2,377 41.61 Loss of -546 on sale
2025-10-28BUY6656.38057.230 57.145USD 3,772 41.30
2025-10-24SELL-2253.32054.970 54.805USD -1,206 41.15 Loss of -300 on sale
2025-10-15BUY13255.85056.225 56.187USD 7,417 40.60
2025-10-02BUY2239.61039.850 39.826USD 876 40.61
2025-09-30BUY4439.73040.200 40.153USD 1,767 40.62
2025-08-21SELL-2236.35036.800 36.755USD -809 40.70 Profit of 87 on sale
2025-07-31BUY6638.26038.540 38.512USD 2,542 40.75
2025-06-30SELL-4443.43044.395 44.299USD -1,949 40.79 Loss of -155 on sale
2025-06-25SELL-2242.99044.110 43.998USD -968 40.73 Loss of -72 on sale
2025-06-20SELL-4441.96042.663 42.593USD -1,874 40.70 Loss of -83 on sale
2025-05-23BUY2239.48040.000 39.948USD 879 40.88
2025-05-19SELL-2239.91040.745 40.661USD -895 40.90 Profit of 5 on sale
2025-05-15SELL-6640.64040.710 40.703USD -2,686 40.90 Profit of 13 on sale
2025-05-12SELL-2239.58040.705 40.593USD -893 40.94 Profit of 8 on sale
2025-05-09SELL-2237.29039.450 39.234USD -863 40.97 Profit of 38 on sale
2025-04-30SELL-2239.25039.770 39.718USD -874 41.16 Profit of 32 on sale
2025-04-24SELL-4437.05037.250 37.230USD -1,638 41.32 Profit of 180 on sale
2025-04-17SELL-2233.11033.380 33.353USD -734 41.70 Profit of 184 on sale
2025-04-15SELL-6632.85034.230 34.092USD -2,250 41.90 Profit of 515 on sale
2025-04-14SELL-6633.28034.050 33.973USD -2,242 41.99 Profit of 529 on sale
2025-04-09SELL-8831.80032.820 32.718USD -2,879 42.36 Profit of 848 on sale
2025-04-07SELL-15432.30032.760 32.714USD -5,038 42.63 Profit of 1,528 on sale
2025-04-04SELL-22032.32033.660 33.526USD -7,376 42.76 Profit of 2,031 on sale
2025-03-31BUY2237.36038.945 38.786USD 853 42.97
2025-03-19SELL-4440.44040.950 40.899USD -1,800 43.28 Profit of 105 on sale
2025-03-14SELL-13239.94041.000 40.894USD -5,398 43.43 Profit of 335 on sale
2025-03-13SELL-4438.33040.030 39.860USD -1,754 43.51 Profit of 160 on sale
2025-03-12SELL-74838.53041.870 41.536USD -31,069 43.58 Profit of 1,528 on sale
2025-03-07SELL-4436.14037.300 37.184USD -1,636 43.83 Profit of 293 on sale
2025-03-06SELL-6635.44035.690 35.665USD -2,354 43.96 Profit of 548 on sale
2025-03-03SELL-2231.39035.200 34.819USD -766 44.59 Profit of 215 on sale
2025-02-28SELL-14,38331.44031.469 31.466USD -452,577 44.80 Profit of 191,817 on sale
2025-02-26SELL-6031.08034.470 34.131USD -2,048 45.28 Profit of 669 on sale
2025-02-25SELL-18033.06033.855 33.775USD -6,080 45.49 Profit of 2,108 on sale
2025-02-18BUY30034.93037.220 36.991USD 11,097 46.56
2025-02-13BUY6036.26036.620 36.584USD 2,195 47.16
2025-02-12BUY6035.50035.590 35.581USD 2,135 47.40
2025-02-11BUY18034.49039.195 38.724USD 6,970 47.67
2025-02-06BUY54041.64041.820 41.802USD 22,573 48.17
2025-01-27BUY6040.22041.940 41.768USD 2,506 49.75
2024-12-30BUY30044.64046.320 46.152USD 13,846 50.56
2024-12-06BUY24049.97050.475 50.424USD 12,102 50.70
2024-12-05BUY6047.16052.920 52.344USD 3,141 50.83
2024-12-04BUY30052.02053.615 53.456USD 16,037 50.78
2024-11-29BUY30045.15045.730 45.672USD 13,702 51.38
2024-11-27BUY24044.70045.400 45.330USD 10,879 51.96
2024-11-26BUY6043.96044.430 44.383USD 2,663 52.32
2024-11-25BUY2,70143.85045.990 45.776USD 123,641 52.72
2024-11-21BUY26042.86046.365 46.015USD 11,964 53.73
2024-11-20BUY15645.04046.700 46.534USD 7,259 54.21
2024-11-18BUY62445.33048.365 48.062USD 29,990 55.25
2024-11-12BUY41657.35061.050 60.680USD 25,243 55.11
2024-11-08BUY25561.12062.230 62.119USD 15,840 54.68
2024-11-07BUY76558.05060.370 60.138USD 46,006 54.42
2024-11-06BUY10258.81060.050 59.926USD 6,112 54.05
2024-10-31BUY5152.04054.720 54.452USD 2,777 53.44
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of APGE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1970,6630123,32357.3%
2025-09-1855,2200144,94238.1%
2025-09-1757,7220155,74637.1%
2025-09-1643,15180105,79040.8%
2025-09-1581,96129130,78662.7%
2025-09-1271,0510214,65033.1%
2025-09-1194,7640386,86724.5%
2025-09-1059,8630142,02842.1%
2025-09-09111,612257182,11561.3%
2025-09-0897,0380179,71054.0%
2025-09-0569,6230171,26240.7%
2025-09-0453,120232144,34436.8%
2025-09-0374,1230144,59351.3%
2025-09-0266,5154129,84551.2%
2025-08-29101,9740154,87165.8%
2025-08-2859,362161162,55236.5%
2025-08-2767,694500137,14849.4%
2025-08-2656,46712108,27152.2%
2025-08-2558,196079,23373.4%
2025-08-22156,8240213,08373.6%
2025-08-21109,2100159,43368.5%
2025-08-2069,7200118,47158.8%
2025-08-19101,7931,831140,03472.7%
2025-08-1864,930092,96969.8%
2025-08-15168,3473,071233,00872.2%
2025-08-1479,489519209,64137.9%
2025-08-13137,5100206,60666.6%
2025-08-1298,0690228,50942.9%
2025-08-11128,020262163,34878.4%
2025-08-08158,4020252,33962.8%
2025-08-0796,25430146,85265.5%
2025-08-06183,75215346,21353.1%
2025-08-05113,13150216,68452.2%
2025-08-0486,0420161,95853.1%
2025-08-01164,1571,952329,21949.9%
2025-07-31116,4000253,05946.0%
2025-07-30120,1010257,28646.7%
2025-07-29131,8820256,50551.4%
2025-07-28147,442296276,56853.3%
2025-07-25113,9740225,87150.5%
2025-07-24124,1445236,30452.5%
2025-07-2385,8770205,61841.8%
2025-07-2297,6130213,62145.7%
2025-07-21183,75260441,69041.6%
2025-07-18119,198324364,43532.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy